FDA Import Refusal AEK-2166161-5/20003/1 — Glenmark Pharmaceuticals Limited
The FDA refused shipment AEK-2166161-5/20003/1 from Glenmark Pharmaceuticals Limited (India) on Oct 9, 2026. The refused product falls under Drugs and Biologics — MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 9, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62FCY53 MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 27